A detailed history of Brevan Howard Capital Management LP transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 19,067 shares of CDMO stock, worth $236,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,067
Previous 42,637 55.28%
Holding current value
$236,240
Previous $304,000 28.95%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.7 - $12.45 $157,919 - $293,446
-23,570 Reduced 55.28%
19,067 $216,000
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $270,318 - $395,671
42,637 New
42,637 $304,000
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $79,956 - $164,737
17,232 New
17,232 $112,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $770M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.